Royce & Associates LP Cardiovascular Systems Inc Transaction History

Royce & Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$42.06 - $51.64 $3.24 Million - $3.98 Million	-77,117 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$33.93 - $43.66 $92,527 - $119,060	-2,727 Reduced 3.42%	77,117 $3.31 Million
Q1 2019 May 09, 2019	BUY	$26.74 - $41.32 $1.2 Million - $1.86 Million	45,000 Added 129.15%	79,844 $3.09 Million
Q4 2018 Feb 11, 2019	BUY	$25.26 - $38.43 $880,159 - $1.34 Million	34,844 New	34,844 $993,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.